NanoString Technologies Inc (NASDAQ:NSTG)

6.33
Delayed Data
As of Nov 25
 -0.16 / -2.47%
Today’s Change
4.37
Today|||52-Week Range
43.81
-85.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$294.3M

Company Description

NanoString Technologies, Inc. engages in the development and commercialization of instruments and services for profiling of genes and proteins from tissue sample. It offers the GeoMx Digital Spatial Profiler, nCounter Analysis System product platforms, GeoMx Assays, nCounter Panels & Assays and CosMx Spatial Molecular. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June, 2003 and is headquartered in Seattle, WA.

Contact Information

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle Washington 98109
P:(888) 358-6266
Investor Relations:
(206) 602-1768

Employees

Shareholders

Other institutional57.98%
Mutual fund holders54.69%
Individual stakeholders15.07%

Top Executives

Robert Bradley GrayPresident, Chief Executive Officer & Director
Mark A. WinhamSenior Vice President-Operations
Kenneth Thomas BaileyChief Financial Officer
Joseph M. BeechemChief Science Officer & SVP-Research & Development
David W. GhesquiereSenior VP-Corporate & Business Development